Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 7469326, 8 pages
Review Article

Nrf2 Is an Attractive Therapeutic Target for Retinal Diseases

1Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan
2Asubio Pharma Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Hyogo 650-0047, Japan

Received 20 July 2016; Revised 7 September 2016; Accepted 21 September 2016

Academic Editor: Takeshi Matsugi

Copyright © 2016 Yasuhiro Nakagami. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yasuhiro Nakagami, “Nrf2 Is an Attractive Therapeutic Target for Retinal Diseases,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 7469326, 8 pages, 2016. doi:10.1155/2016/7469326